Cited by 130TGF-β signaling in diseasesT-cell and B-cell ImmunologyImmunotherapy and Immune Responses

T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine

Open access
Donkor, Moses K., Sarkar, Abira, Savage, Peter A., Franklin, Ruth A., Johnson, Linda K., Jungbluth, Achim A., Allison, James P., Li, Ming O.·2011·Immunity

Abstract

Tolerance induction in T cells takes place in most tumors and is thought to account for tumor evasion from immune eradication. Production of the cytokine TGF-β is implicated in immunosuppression, but the cellular mechanism by which TGF-β induces T cell dysfunction remains unclear. With a transgenic model of prostate cancer, we showed that tumor development was not suppressed by the adaptive immune system, which was associated with heightened TGF-β signaling in T cells from the tumor-draining lymph nodes. Blockade of TGF-β signaling in T cells enhanced tumor antigen-specific T cell responses and inhibited tumor development. Surprisingly, T cell- but not Treg cell-specific ablation of TGF-β1 was sufficient to augment T cell cytotoxic activity and blocked tumor growth and metastases. These findings reveal that T cell production of TGF-β1 is an essential requirement for tumors to evade immunosurveillance independent of TGF-β produced by tumors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2011.04.019

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Single cell analyses reveal extensive phenotype heterogeneity among Treg cells.

    “As single cell analyses reveal extensive phenotype heterogeneity among Treg cells221”

    From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [221]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 57 · Cited by 130

Authors
Donkor, M. K., Sarkar, A., Savage, P. A., Franklin, R. A., Johnson, L. K., Jungbluth, A. A., Allison, J. P., & Li, M. O.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • Ludwig Cancer Research (BE)
Corresponding author
Li, Ming O.
Venue
Immunity
Publisher
Elsevier BV
Published
2011-07
Volume
35
Issue
1
Pages
123-134
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2160860231
Cited by
130
References
57
Citations by year
2026: 3 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 9 · 2021: 16 · 2020: 10 · 2019: 10 · 2018: 4 · 2017: 10 · 2016: 7 · 2015: 5 · 2014: 14 · 2013: 11 · 2012: 6
FWCI
4.26
Type
journal article
Language
en
Open access
Locations
  • Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR053595, K01AR053595, R01AR060723, AR060723)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
TGF-β1, prostate cancer, tumor immune evasion, T cell tolerance, T cell dysfunction, T cell cytotoxicity, tumor antigen-specific T cell responses, tumor-draining lymph nodes, metastasis
MeSH terms
Adenocarcinoma, Animals, Cytotoxicity, Immunologic, Disease Models, Animal, Humans, Immune Tolerance, Immunologic Surveillance, Lymphocyte Depletion, Male, Mice, Transgenic, Oncogenes, Prostatic Neoplasms, Receptors, Antigen, T-Cell, Signal Transduction, T-Lymphocyte Subsets, Transforming Growth Factor beta, Tumor Escape, Cell Growth Processes, T-Lymphocytes, Regulatory, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review